Evaluation of oxidized low-density lipoprotein in the coronary circulation of patients with coronary artery disease, and its association with percutaneous coronary intervention

International Journal of Cardiology

Volumn 134, Issue 3, 2009, Pages

  Ramadan, Mahmoud M ^a   Kodama, Makoto ^a   Hirono, Satoru ^a   Okura, Yuji ^a   Mitsuma, Wataru ^a   Ito, Masahiro ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Atherosclerosis; Coronary artery disease; Coronary sinus; Oxidized low density lipoprotein; Percutaneous coronary intervention

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED;

EID: 67349189133     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.01.025     Document Type: Article

References (10)

1. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88 (1991) 1785-1792
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272 (1997) 20963-20966
3. Yamashita H., Ehara S., Yoshiyama M., et al. Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina. Circ J 71 (2007) 681-687
4. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low-density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
5. Tsimikas S., Lau H.K., Han K.R., et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein (a) short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109 (2004) 3164-3170
6. Mitsuma W., Kodama M., Hirono S., et al. Angiopoietin-1, angiopoietin-2, and tie-2 in the coronary circulation of patients with and without coronary collateral vessels. Circulation J 71 (2007) 343-347
7. Ellis S.G., Vandormael M.G., Cowley M.J., et al. for the Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 82 (1990) 1193-1202
8. Kotani K., Maekawa M., Kanno T., Kondo A., Toda N., and Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochem Biophys Acta 1215 (1994) 111-118
9. Mitsuma W., Kodama M., Hanawa H., et al. Serum endostatin in the coronary circulation of patients with coronary heart disease and its relation to coronary collateral formation. Am J Cardiol 99 (2007) 494-498
10. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103 (1999) 1547-1560